Clinical Trial Update: Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluated the effect of early L-carnitine supplementation on neurodevelopmental outcomes in very preterm infants; results completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurodevelopmental Disorder
• Prematurity

Drugs mentioned

• L-carnitine (L-carnitine)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Prematurity, Neurodevelopmental Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-03-08